Can a computer accurately measure lung scarring on CT scans?
Part of Lungs & breathing clinical trials.
This study checks if a computer program can reliably measure the amount of lung scarring on chest CT scans. It's for people with certain types of interstitial lung disease who are already scheduled for a routine CT scan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have a type of lung scarring called interstitial lung disease, either from idiopathic pulmonary fibrosis or a connective tissue disease (like scleroderma or lupus)
- You are being seen at one of the participating hospitals in France
- You need a chest CT scan as part of your regular follow-up
- You are covered by French national health insurance
- You are able to hold your breath for 10 seconds and are not pregnant or having a lung flare-up
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how well a CT scan and lung function tests can measure interstitial lung disease (ILD), which is long-term scarring or inflammation in the lungs. It may help doctors use these images and tests more accurately to track ILD.
This study tests whether an AI tool can correctly find lung scarring (pulmonary fibrosis) on CT scans as well as doctors do. The results could lead to faster, more consistent detection of this condition.
This study looks at what factors contribute to worsening lung scarring seen on scans in people with certain lung diseases. Results may help doctors better understand and predict who will worsen over time.
This study follows people who are being seen for lung scarring (also called ILD) and compares them with family members without lung scarring. It helps researchers better understand how this condition changes over time and what to look for in the future.
This study helps doctors identify early signs of lung scarring (fibrosis) in patients with autoimmune diseases like scleroderma, rheumatoid arthritis, and Sjögren's syndrome. By catching this early, researchers hope to better understand and treat these complications.
This trial uses a special PET/MRI scan to look for early signs of lung scarring and inflammation using a “collagen-targeting” tracer. It may help doctors better identify early interstitial lung disease (IL D) and track it over time.
Hear when a new Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.